| Bioactivity | MA-PEG4-VC-PAB-DMEA-duocarmycin DM is a drug-linker conjugate for ADC by using the anticancer antibiotic Duocarmycin DM (HY-130978), linked via MA-PEG4-vc-PAB-DMEA (HY-126668)[1][2]. |
| Name | MA-PEG4-VC-PAB-DMEA-duocarmycin DM |
| Formula | C68H89ClN12O17 |
| Molar Mass | 1381.96 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Patil PC, et al. A Short Review on the Synthetic Strategies of Duocarmycin Analogs that are Powerful DNA Alkylating Agents. Anticancer Agents Med Chem. 2015;15(5):616-30. [2]. Italo Beria, et al. New alkylating agents. Franch, WO2013149948A1. |
MA-PEG4-VC-PAB-DMEA-duocarmycin DM
CAS: F: C68H89ClN12O17 W: 1381.96
MA-PEG4-VC-PAB-DMEA-duocarmycin DM is a drug-linker conjugate for ADC by using the anticancer antibiotic Duocarmycin DM
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.